In vitro activity of Bay Y3118 against anaerobic bacteria.

The antimicrobial activity of a new quinolone, Bay Y3118, was determined against 326 strains of anaerobic bacteria and compared with the activities of ampicillin-sulbactam, cefotetan, clindamycin, imipenem, metronidazole, and sparfloxacin. The National Committee for Clinical Laboratory Standards-app...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Wexler, H M, Molitoris, E, Finegold, S M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192422/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8285647/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.11.2509
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!